Follow
Roger Cachope, MD MS
Roger Cachope, MD MS
Director, Systems Neurobiology
Verified email at chdifoundation.org - Homepage
Title
Cited by
Cited by
Year
Selective Activation of Cholinergic Interneurons Enhances Accumbal Phasic Dopamine Release: Setting the Tone for Reward Processing
R Cachope, Y Mateo, BN Mathur, J Irving, HL Wang, M Morales, ...
Cell Reports, 2012
5122012
Ventral hippocampal afferents to the nucleus accumbens regulate susceptibility to depression
RC Bagot, EM Parise, CJ Pena, HX Zhang, I Maze, D Chaudhury, ...
Nature communications 6 (1), 7062, 2015
4692015
ΔFosB induction in striatal medium spiny neuron subtypes in response to chronic pharmacological, emotional, and optogenetic stimuli
MK Lobo, S Zaman, DM Damez-Werno, JW Koo, RC Bagot, JA DiNieri, ...
Journal of Neuroscience 33 (47), 18381-18395, 2013
2462013
Gap junction-mediated electrical transmission: regulatory mechanisms and plasticity
AE Pereda, S Curti, G Hoge, R Cachope, CE Flores, JE Rash
Biochimica et Biophysica Acta (BBA)-Biomembranes 1828 (1), 134-146, 2013
1912013
Endocannabinoids shape accumbal encoding of cue-motivated behavior via CB1 receptor activation in the ventral tegmentum
EB Oleson, MV Beckert, JT Morra, CS Lansink, R Cachope, RA Abdullah, ...
Neuron 73 (2), 360-373, 2012
1712012
Unravelling and exploiting astrocyte dysfunction in Huntington’s disease
BS Khakh, V Beaumont, R Cachope, I Munoz-Sanjuan, SA Goldman, ...
Trends in neurosciences 40 (7), 422-437, 2017
1702017
Local control of striatal dopamine release
R Cachope, JF Cheer
Frontiers in behavioral neuroscience 8, 188, 2014
1642014
Dorsal raphe dual serotonin-glutamate neurons drive reward by establishing excitatory synapses on VTA mesoaccumbens dopamine neurons
HL Wang, S Zhang, J Qi, H Wang, R Cachope, CA Mejias-Aponte, ...
Cell reports 26 (5), 1128-1142. e7, 2019
1362019
Endocannabinoid actions on cortical terminals orchestrate local modulation of dopamine release in the nucleus accumbens
Y Mateo, KA Johnson, DP Covey, BK Atwood, HL Wang, S Zhang, ...
Neuron 96 (5), 1112-1126. e5, 2017
1072017
Potentiation of electrical and chemical synaptic transmission mediated by endocannabinoids
R Cachope, K Mackie, A Triller, J O'Brien, AE Pereda
Neuron 56 (6), 1034-1047, 2007
1012007
Functional diversity on synaptic plasticity mediated by endocannabinoids
R Cachope
Philosophical Transactions of the Royal Society B 367 (1607), 3242-53, 2012
482012
Reduced levels of Cacna1c attenuate mesolimbic dopamine system function
CE Terrillion, DT Dao, R Cachope, MK Lobo, AC Puche, JF Cheer, ...
Genes, Brain and Behavior 16 (5), 495-505, 2017
352017
Variability of distribution of Ca2+/calmodulin-dependent kinase II at mixed synapses on the mauthner cell: colocalization and association with connexin 35
CE Flores, R Cachope, S Nannapaneni, S Ene, AC Nairn, AE Pereda
Journal of Neuroscience 30 (28), 9488-9499, 2010
332010
Cannabinoid receptor activation shifts temporally engendered patterns of dopamine release
EB Oleson, R Cachope, A Fitoussi, K Tsutsui, S Wu, JA Gallegos, ...
Neuropsychopharmacology 39 (6), 1441-1452, 2014
312014
Chronic lithium treatment rectifies maladaptive dopamine release in the nucleus accumbens
A Can, DO Frost, R Cachope, JF Cheer, TD Gould
Journal of neurochemistry 139 (4), 576-585, 2016
272016
Possible use of a H3R antagonist for the management of nonmotor symptoms in the Q175 mouse model of Huntington's disease
DS Whittaker, HB Wang, DH Loh, R Cachope, CS Colwell
Pharmacology Research & Perspectives 5 (5), e00344, 2017
202017
Subsecond regulation of synaptically released dopamine by COMT in the olfactory bulb
R Cockerham, S Liu, R Cachope, E Kiyokage, JF Cheer, MT Shipley, ...
Journal of Neuroscience 36 (29), 7779-7785, 2016
192016
Two independent forms of activity-dependent potentiation regulate electrical transmission at mixed synapses on the Mauthner cell
R Cachope, AE Pereda
Brain research 1487, 173-182, 2012
182012
Enhanced striatopallidal gamma‐aminobutyric acid (GABA)A receptor transmission in mouse models of huntington's disease
T Perez‐Rosello, S Gelman, G Tombaugh, R Cachope, V Beaumont, ...
Movement Disorders 34 (5), 684-696, 2019
162019
Optimization of potent and selective ataxia telangiectasia-mutated inhibitors suitable for a proof-of-concept study in Huntington’s disease models
L Toledo-Sherman, P Breccia, R Cachope, JR Bate, I Angulo-Herrera, ...
Journal of Medicinal Chemistry 62 (6), 2988-3008, 2019
132019
The system can't perform the operation now. Try again later.
Articles 1–20